Nucleic acid-sensing receptors: Rheostats of autoimmunity and autoinflammation

Journal of Immunology

Volumn 195, Issue 8, 2015, Pages 3507-3512

  Sharma, Shruti ^a   Fitzgerald, Katharine A ^a   Cancro, Michael P ^b   Marshak Rothstein, Ann ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; MEMBRANE RECEPTOR; NUCLEIC ACID; NUCLEIC ACID SENSOR RECEPTOR; STIMULATOR OF TYPE I IFN GENE PROTEIN; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG; DNA; MPYS PROTEIN, HUMAN; RNA; TLR9 PROTEIN, HUMAN;

AUTOIMMUNITY; AUTOINFLAMMATORY DISEASE; CELL DEATH; CYTOSOL; DISEASE ACTIVITY; DISEASE ASSOCIATION; HUMAN; IMMUNE RESPONSE; MOLECULAR PATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; AUTOIMMUNE DISEASE; IMMUNOLOGY; MOUSE;

ANIMALS; AUTOIMMUNE DISEASES; DNA; HUMANS; MEMBRANE PROTEINS; MICE; RNA; TOLL-LIKE RECEPTOR 9;

EID: 84943524718     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1500964     Document Type: Review

References (82)

1. Hemmi, H., O. Takeuchi, T. Kawai, T. Kaisho, S. Sato, H. Sanjo, M. Matsumoto, K. Hoshino, H. Wagner, K. Takeda, and S. Akira. 2000. A Toll-like receptor recognizes bacterial DNA. Nature 408:740-745.
2. Kawai, T., and S. Akira. 2010. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11:373-384.
3. Leadbetter, E. A., I. R. Rifkin, A. M. Hohlbaum, B. C. Beaudette, M. J. Shlomchik, and A. Marshak-Rothstein. 2002. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416:603-607.
4. Lau, C. M., C. Broughton, A. S. Tabor, S. Akira, R. A. Flavell, M. J. Mamula, S. R. Christensen, M. J. Shlomchik, G. A. Viglianti, I. R. Rifkin, and A. Marshak-Rothstein. 2005. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J. Exp. Med. 202:1171-1177.
5. Vollmer, J., S. Tluk, C. Schmitz, S. Hamm, M. Jurk, A. Forsbach, S. Akira, K. M. Kelly, W. H. Reeves, S. Bauer, and A. M. Krieg. 2005. Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8. J. Exp. Med. 202:1575-1585.
6. Christensen, S. R., J. Shupe, K. Nickerson, M. Kashgarian, R. A. Flavell, and M. J. Shlomchik. 2006. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 25:417-428.
7. Nickerson, K. M., S. R. Christensen, J. Shupe, M. Kashgarian, D. Kim, K. Elkon, and M. J. Shlomchik. 2010. TLR9 regulates TLR7- and MyD88-dependent autoantibody production and disease in a murine model of lupus. J. Immunol. 184:1840-1848.
8. Kono, D. H., M. K. Haraldsson, B. R. Lawson, K. M. Pollard, Y. T. Koh, X. Du, C. N. Arnold, R. Baccala, G. J. Silverman, B. A. Beutler, and A. N. Theofilopoulos. 2009. Endosomal TLR signaling is required for anti-nucleic acid and rheumatoid factor autoantibodies in lupus. Proc. Natl. Acad. Sci. USA 106:12061-12066.
9. Pawaria, S., K. Moody, P. Busto, K. Nündel, C. H. Choi, T. Ghayur, and A. Marshak-Rothstein. 2015. Cutting Edge: DNase II deficiency prevents activation of autoreactive B cells by double-stranded DNA endogenous ligands. J. Immunol. 194:1403-1407.
10. Yasuda, K., C. Richez, J. W. Maciaszek, N. Agrawal, S. Akira, A. Marshak-Rothstein, and I. R. Rifkin. 2007. Murine dendritic cell type I IFN production induced by human IgG-RNA immune complexes is IFN regulatory factor (IRF) 5 and IRF7 dependent and is required for IL-6 production. J. Immunol. 178:6876-6885.
11. Savarese, E., C. Steinberg, R. D. Pawar, W. Reindl, S. Akira, H. J. Anders, and A. Krug. 2008. Requirement of Toll-like receptor 7 for pristane-induced production of autoantibodies and development of murine lupus nephritis. Arthritis Rheum. 58:1107-1115.
12. Berland, R., L. Fernandez, E. Kari, J. H. Han, I. Lomakin, S. Akira, H. H. Wortis, J. F. Kearney, A. A. Ucci, and T. Imanishi-Kari. 2006. Toll-like receptor 7-dependent loss of B cell tolerance in pathogenic autoantibody knockin mice. Immunity 25:429-440.
13. Lee, P. Y., Y. Kumagai, Y. Li, O. Takeuchi, H. Yoshida, J. Weinstein, E. S. Kellner, D. Nacionales, T. Barker, K. Kelly-Scumpia, et al. 2008. TLR7-dependent and FcgammaR-independent production of type I interferon in experimental mouse lupus. J. Exp. Med. 205:2995-3006.
14. Jackson, S. W., N. E. Scharping, N. S. Kolhatkar, S. Khim, M. A. Schwartz, Q. Z. Li, K. L. Hudkins, C. E. Alpers, D. Liggitt, and D. J. Rawlings. 2014. Opposing impact of B cell-intrinsic TLR7 and TLR9 signals on autoantibody repertoire and systemic inflammation. J. Immunol. 192:4525-4532.
15. Pisitkun, P., J. A. Deane, M. J. Difilippantonio, T. Tarasenko, A. B. Satterthwaite, and S. Bolland. 2006. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 312:1669-1672.
16. Subramanian, S., K. Tus, Q. Z. Li, A. Wang, X. H. Tian, J. Zhou, C. Liang, G. Bartov, L. D. McDaniel, X. J. Zhou, et al. 2006. A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proc. Natl. Acad. Sci. USA 103:9970-9975.
17. Hwang, S. H., H. Lee, M. Yamamoto, L. A. Jones, J. Dayalan, R. Hopkins, X. J. Zhou, F. Yarovinsky, J. E. Connolly, M. A. Curotto de Lafaille, et al. 2012. B cell TLR7 expression drives anti-RNA autoantibody production and exacerbates disease in systemic lupus erythematosus-prone mice. J. Immunol. 189:5786-5796.
18. Deane, J. A., P. Pisitkun, R. S. Barrett, L. Feigenbaum, T. Town, J. M. Ward, R. A. Flavell, and S. Bolland. 2007. Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. Immunity 27:801-810.
19. Sun, X., A. Wiedeman, N. Agrawal, T. H. Teal, L. Tanaka, K. L. Hudkins, C. E. Alpers, S. Bolland, M. B. Buechler, J. A. Hamerman, et al. 2013. Increased ribonuclease expression reduces inflammation and prolongs survival in TLR7 transgenic mice. J. Immunol. 190:2536-2543.
20. Umiker, B. R., S. Andersson, L. Fernandez, P. Korgaokar, A. Larbi, M. Pilichowska, C. C. Weinkauf, H. H. Wortis, J. F. Kearney, and T. Imanishi-Kari. 2014. Dosage of X-linked Toll-like receptor 8 determines gender differences in the development of systemic lupus erythematosus. Eur. J. Immunol. 44:1503-1516.
21. Guiducci, C., M. Gong, A. M. Cepika, Z. Xu, C. Tripodo, L. Bennett, C. Crain, P. Quartier, J. J. Cush, V. Pascual, et al. 2013. RNA recognition by human TLR8 can lead to autoimmune inflammation. J. Exp. Med. 210:2903-2919.
22. Clancy, R. M., D. Alvarez, E. Komissarova, F. J. Barrat, J. Swartz, and J. P. Buyon. 2010. Ro60-associated single-stranded RNA links inflammation with fetal cardiac fibrosis via ligation of TLRs: a novel pathway to autoimmune-associated heart block. J. Immunol. 184:2148-2155.
23. Graham, R. R., C. Kyogoku, S. Sigurdsson, I. A. Vlasova, L. R. Davies, E. C. Baechler, R. M. Plenge, T. Koeuth, W. A. Ortmann, G. Hom, et al. 2007. Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc. Natl. Acad. Sci. USA 104:6758-6763.
24. Napirei, M., A. Gültekin, T. Kloeckl, T. Möröy, J. Frostegård, and H. G. Mannherz. 2006. Systemic lupus-erythematosus: deoxyribonuclease 1 in necrotic chromatin disposal. Int. J. Biochem. Cell Biol. 38:297-306.
25. Al-Mayouf, S. M., A. Sunker, R. Abdwani, S. A. Abrawi, F. Almurshedi, N. Alhashmi, A. Al Sonbul, W. Sewairi, A. Qari, E. Abdallah, et al. 2011. Loss-offunction variant in DNASE1L3 causes a familial form of systemic lupus erythematosus. Nat. Genet. 43:1186-1188.
26. Crow, Y. J., B. E. Hayward, R. Parmar, P. Robins, A. Leitch, M. Ali, D. N. Black, H. van Bokhoven, H. G. Brunner, B. C. Hamel, et al. 2006. Mutations in the gene encoding the 39-59 DNA exonuclease TREX1 cause Aicardi-Goutières syndrome at the AGS1 locus. Nat. Genet. 38:917-920.
27. Rice, G. I., J. Bond, A. Asipu, R. L. Brunette, I. W. Manfield, I. M. Carr, J. C. Fuller, R. M. Jackson, T. Lamb, T. A. Briggs, et al. 2009. Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response. Nat. Genet. 41:829-832.
28. Rice, G. I., P. R. Kasher, G. M. Forte, N. M. Mannion, S. M. Greenwood, M. Szynkiewicz, J. E. Dickerson, S. S. Bhaskar, M. Zampini, T. A. Briggs, et al. 2012. Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature. Nat. Genet. 44:1243-1248.
29. Rice, G. I., M. A. Reijns, S. R. Coffin, G. M. Forte, B. H. Anderson, M. Szynkiewicz, H. Gornall, D. Gent, A. Leitch, M. P. Botella, et al. 2013. Synonymous mutations in RNASEH2A create cryptic splice sites impairing RNase H2 enzyme function in Aicardi-Goutières syndrome. Hum. Mutat. 34:1066-1070.
30. Crow, Y. J., and J. Rehwinkel. 2009. Aicardi-Goutieres syndrome and related phenotypes: linking nucleic acid metabolism with autoimmunity. Hum. Mol. Genet. 18(R2):R130-R136.
31. Stetson, D. B., J. S. Ko, T. Heidmann, and R. Medzhitov. 2008. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 134:587-598.
32. Stetson, D. B. 2012. Endogenous retroelements and autoimmune disease. Curr. Opin. Immunol. 24:692-697.
33. Gall, A., P. Treuting, K. B. Elkon, Y. M. Loo, M. Gale, Jr., G. N. Barber, and D. B. Stetson. 2012. Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease. Immunity 36:120-131.
34. Okabe, Y., K. Kawane, S. Akira, T. Taniguchi, and S. Nagata. 2005. Toll-like receptor-independent gene induction program activated by mammalian DNA escaped from apoptotic DNA degradation. J. Exp. Med. 202:1333-1339.
35. Yoshida, H., Y. Okabe, K. Kawane, H. Fukuyama, and S. Nagata. 2005. Lethal anemia caused by interferon-beta produced in mouse embryos carrying undigested DNA. Nat. Immunol. 6:49-56.
36. Kawane, K., M. Ohtani, K. Miwa, T. Kizawa, Y. Kanbara, Y. Yoshioka, H. Yoshikawa, and S. Nagata. 2006. Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages. Nature 443:998-1002.
37. Kawane, K., H. Tanaka, Y. Kitahara, S. Shimaoka, and S. Nagata. 2010. Cytokinedependent but acquired immunity-independent arthritis caused by DNA escaped from degradation. Proc. Natl. Acad. Sci. USA 107:19432-19437.
38. Kimura-Kataoka, K., T. Yasuda, J. Fujihara, T. Toga, R. Ono, Y. Otsuka, M. Ueki, R. Iida, R. Sano, T. Nakajima, et al. 2012. Genetic and expression analysis of SNPs in the human deoxyribonuclease II: SNPs in the promoter region reduce its in vivo activity through decreased promoter activity. Electrophoresis 33:2852-2858.
39. Arvio, M. A., J. M. Rapola, and P. M. Pelkonen. 1998. Chronic arthritis in patients with aspartylglucosaminuria. J. Rheumatol. 25:1131-1134.
40. Morishita, K., and R. E. Petty. 2011. Musculoskeletal manifestations of mucopolysaccharidoses. Rheumatology (Oxford) 50(Suppl. 5):v19-v25.
41. Li, X. D., J. Wu, D. Gao, H. Wang, L. Sun, and Z. J. Chen. 2013. Pivotal roles of cGAS-cGAMP signaling in antiviral defense and immune adjuvant effects. Science 341:1390-1394.
42. Unterholzner, L., S. E. Keating, M. Baran, K. A. Horan, S. B. Jensen, S. Sharma, C. M. Sirois, T. Jin, E. Latz, T. S. Xiao, et al. 2010. IFI16 is an innate immune sensor for intracellular DNA. Nat. Immunol. 11:997-1004.
43. Xiao, T. S., and K. A. Fitzgerald. 2013. The cGAS-STING pathway for DNA sensing. Mol. Cell 51:135-139.
44. Ahn, J., D. Gutman, S. Saijo, and G. N. Barber. 2012. STING manifests self DNAdependent inflammatory disease. Proc. Natl. Acad. Sci. USA 109:19386-19391.
45. Jeremiah, N., B. Neven, M. Gentili, I. Callebaut, S. Maschalidi, M. C. Stolzenberg, N. Goudin, M. L. Frémond, P. Nitschke, T. J. Molina, et al. 2014. Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations. J. Clin. Invest. 124:5516-5520.
46. Liu, Y., A. A. Jesus, B. Marrero, D. Yang, S. E. Ramsey, G. A. Montealegre Sanchez, K. Tenbrock, H. Wittkowski, O. Y. Jones, H. S. Kuehn, et al. 2014. Activated STING in a vascular and pulmonary syndrome. N. Engl. J. Med. 371:507-518.
47. Casciola-Rosen, L. A., G. Anhalt, and A. Rosen. 1994. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. 179:1317-1330.
48. Green, D. R., T. Ferguson, L. Zitvogel, and G. Kroemer. 2009. Immunogenic and tolerogenic cell death. Nat. Rev. Immunol. 9:353-363.
49. Nagata, S. 2010. Apoptosis and autoimmune diseases. Ann. N. Y. Acad. Sci. 1209:10-16.
50. Shlomchik, M. J. 2009. Activating systemic autoimmunity: B's, T's, and tolls. Curr. Opin. Immunol. 21:626-633.
51. Lan, Y. Y., D. Londoño, R. Bouley, M. S. Rooney, and N. Hacohen. 2014. Dnase2a deficiency uncovers lysosomal clearance of damaged nuclear DNA via autophagy. Cell Reports 9:180-192.
52. Rongvaux, A., R. Jackson, C. C. Harman, T. Li, A. P. West, M. R. de Zoete, Y. Wu, B. Yordy, S. A. Lakhani, C. Y. Kuan, et al. 2014. Apoptotic caspases prevent the induction of type I interferons by mitochondrial DNA. Cell 159:1563-1577.
53. West, A. P., W. Khoury-Hanold, M. Staron, M. C. Tal, C. M. Pineda, S. M. Lang, M. Bestwick, B. A. Duguay, N. Raimundo, D. A. MacDuff, et al. 2015. Mitochondrial DNA stress primes the antiviral innate immune response. Nature 520:553-557.
54. Goodier, J. L., and H. H. Kazazian, Jr. 2008. Retrotransposons revisited: the restraint and rehabilitation of parasites. Cell 135:23-35.
55. Young, G. R., U. Eksmond, R. Salcedo, L. Alexopoulou, J. P. Stoye, and G. Kassiotis. 2012. Resurrection of endogenous retroviruses in antibody-deficient mice. Nature 491:774-778.
56. Zeng, M., Z. Hu, X. Shi, X. Li, X. Zhan, X. D. Li, J. Wang, J. H. Choi, K. W. Wang, T. Purrington, et al. 2014. MAVS, cGAS, and endogenous retroviruses in T-independent B cell responses. Science 346:1486-1492.
57. Platt, F. M., B. Boland, and A. C. van der Spoel. 2012. The cell biology of disease: lysosomal storage disorders: the cellular impact of lysosomal dysfunction. J. Cell Biol. 199:723-734.
58. Baum, R., S. Sharma, S. Carpenter, Q. Z. Li, P. Busto, K. A. Fitzgerald, A. Marshak-Rothstein, and E. M. Gravallese. 2015. Cutting edge: AIM2 and endosomal TLRs differentially regulate arthritis and autoantibody production in DNase II-deficient mice. J. Immunol. 194:873-877.
59. Arnoult, D., F. Soares, I. Tattoli, and S. E. Girardin. 2011. Mitochondria in innate immunity. EMBO Rep. 12:901-910.
60. White, M. J., K. McArthur, D. Metcalf, R. M. Lane, J. C. Cambier, M. J. Herold, M. F. van Delft, S. Bedoui, G. Lessene, M. E. Ritchie, et al. 2014. Apoptotic caspases suppress mtDNA-induced STING-mediated type I IFN production. Cell 159:1549-1562.
61. Lartigue, A., P. Courville, I. Auquit, A. François, C. Arnoult, F. Tron, D. Gilbert, and P. Musette. 2006. Role of TLR9 in anti-nucleosome and anti-DNA antibody production in lpr mutation-induced murine lupus. J. Immunol. 177:1349-1354.
62. Santiago-Raber, M. L., I. Dunand-Sauthier, T. Wu, Q. Z. Li, S. Uematsu, S. Akira, W. Reith, C. Mohan, B. L. Kotzin, and S. Izui. 2010. Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice. J. Autoimmun. 34:339-348.
63. Yu, P., U. Wellmann, S. Kunder, L. Quintanilla-Martinez, L. Jennen, N. Dear, K. Amann, S. Bauer, T. H. Winkler, and H. Wagner. 2006. Toll-like receptor 9-independent aggravation of glomerulonephritis in a novel model of SLE. Int. Immunol. 18:1211-1219.
64. Lee, B. L., J. E. Moon, J. H. Shu, L. Yuan, Z. R. Newman, R. Schekman, and G. M. Barton. 2013. UNC93B1 mediates differential trafficking of endosomal TLRs. eLife 2:e00291.
65. Avalos, A. M., O. Kirak, J. M. Oelkers, M. C. Pils, Y. M. Kim, M. Ottinger, R. Jaenisch, H. L. Ploegh, and M. M. Brinkmann. 2013. Cell-specific TLR9 trafficking in primary APCs of transgenic TLR9-GFP mice. J. Immunol. 190:695-702.
66. Stoehr, A. D., C. T. Schoen, M. M. Mertes, S. Eiglmeier, V. Holecska, A. K. Lorenz, T. Schommartz, A. L. Schoen, C. Hess, A. Winkler, et al. 2011. TLR9 in peritoneal B-1β cells is essential for production of protective self-reactive IgM to control Th17 cells and severe autoimmunity. J. Immunol. 187:2953-2965.
67. Nündel, K., N. M. Green, A. L. Shaffer, K. L. Moody, P. Busto, D. Eilat, K. Miyake, M. A. Oropallo, M. P. Cancro, and A. Marshak-Rothstein. 2015. Cellintrinsic expression of TLR9 in autoreactive B cells constrains BCR/TLR7-dependent responses. J. Immunol. 194:2504-2512.
68. Isnardi, I., Y. S. Ng, I. Srdanovic, R. Motaghedi, S. Rudchenko, H. von Bernuth, S. Y. Zhang, A. Puel, E. Jouanguy, C. Picard, et al. 2008. IRAK-4- and MyD88-dependent pathways are essential for the removal of developing autoreactive B cells in humans. Immunity 29:746-757.
69. Nickerson, K. M., S. R. Christensen, J. L. Cullen, W. Meng, E. T. Luning Prak, and M. J. Shlomchik. 2013. TLR9 promotes tolerance by restricting survival of anergic anti-DNA B cells, yet is also required for their activation. J. Immunol. 190:1447-1456.
70. Sharma, S., A. M. Campbell, J. Chan, S. A. Schattgen, G. M. Orlowski, R. Nayar, A. H. Huyler, K. Nündel, C. Mohan, L. J. Berg, et al. 2015. Suppression of systemic autoimmunity by the innate immune adaptor STING. Proc. Natl. Acad. Sci. USA 112:E710-E717.
71. Dong, G., M. You, L. Ding, H. Fan, F. Liu, D. Ren, and Y. Hou. 2015. STING Negatively Regulates Double-Stranded DNA-Activated JAK1-STAT1 Signaling via SHP-1/2 in B Cells. Mol. Cells 38:441-451.
72. Chen, H., H. Sun, F. You, W. Sun, X. Zhou, L. Chen, J. Yang, Y. Wang, H. Tang, Y. Guan, et al. 2011. Activation of STAT6 by STING is critical for antiviral innate immunity. Cell 147:436-446.
73. Lawrence, T., and G. Natoli. 2011. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat. Rev. Immunol. 11:750-761.
74. Ravishankar, B., H. Liu, R. Shinde, P. Chandler, B. Baban, M. Tanaka, D. H. Munn, A. L. Mellor, M. C. Karlsson, and T. L. McGaha. 2012. Tolerance to apoptotic cells is regulated by indoleamine 2, 3-dioxygenase. Proc. Natl. Acad. Sci. USA 109:3909-3914.
75. Jin, J., H. Hu, H. S. Li, J. Yu, Y. Xiao, G. C. Brittain, Q. Zou, X. Cheng, F. A. Mallette, S. S. Watowich, and S. C. Sun. 2014. Noncanonical NF-κB pathway controls the production of type I interferons in antiviral innate immunity. Immunity 40:342-354.
76. Negishi, H., H. Yanai, A. Nakajima, R. Koshiba, K. Atarashi, A. Matsuda, K. Matsuki, S. Miki, T. Doi, A. Aderem, et al. 2012. Cross-interference of RLR and TLR signaling pathways modulates antibacterial T cell responses. Nat. Immunol. 13:659-666.
77. Parroche, P., F. N. Lauw, N. Goutagny, E. Latz, B. G. Monks, A. Visintin, K. A. Halmen, M. Lamphier, M. Olivier, D. C. Bartholomeu, et al. 2007. Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9. Proc. Natl. Acad. Sci. USA 104:1919-1924.
78. Wu, X., N. M. Gowda, S. Kumar, and D. C. Gowda. 2010. Protein-DNA complex is the exclusive malaria parasite component that activates dendritic cells and triggers innate immune responses. J. Immunol. 184:4338-4348.
79. Sharma, S., R. B. DeOliveira, P. Kalantari, P. Parroche, N. Goutagny, Z. Jiang, J. Chan, D. C. Bartholomeu, F. Lauw, J. P. Hall, et al. 2011. Innate immune recognition of an AT-rich stem-loop DNA motif in the Plasmodium falciparum genome. Immunity 35:194-207.
80. Tabeta, K., P. Georgel, E. Janssen, X. Du, K. Hoebe, K. Crozat, S. Mudd, L. Shamel, S. Sovath, J. Goode, et al. 2004. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc. Natl. Acad. Sci. USA 101:3516-3521.
81. Zucchini, N., G. Bessou, S. Traub, S. H. Robbins, S. Uematsu, S. Akira, L. Alexopoulou, and M. Dalod. 2008. Cutting edge: Overlapping functions of TLR7 and TLR9 for innate defense against a herpesvirus infection. J. Immunol. 180:5799-5803.
82. Schoggins, J. W., D. A. MacDuff, N. Imanaka, M. D. Gainey, B. Shrestha, J. L. Eitson, K. B. Mar, R. B. Richardson, A. V. Ratushny, V. Litvak, et al. 2014. Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity. Nature 505:691-695.